Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin bags tentative USFDA okay for Abacavir, Dolutegravir, Lamivudine Tablets for Oral Suspension for HIV treatment Ruchika Sharma6 Dec 2024 2:56 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
WHO issues warning for growing resistance to HIV drug of GSK Roshni Dhar11 March 2024 5:58 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Health Bulletin 11/ March/ 2024 Roshni Dhar11 March 2024 4:58 PM ISTHere are the top health news for the day:NEET UG 2024 registration deadline extendedThe deadline for NEET 2024 application submissions has been...
WHO warns of growing resistance to GSK HIV drug Ruchika Sharma6 March 2024 12:30 PM ISTThe World Health Organization (WHO) has said resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing...
Strides Pharma Science Singapore gets tentative USFDA approval for Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate tablets Ruchika Sharma16 Sept 2023 12:30 PM ISTBangalore: Strides Pharma Science Limited has announced that its step‐ down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore,...
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
Novel HIV drug formulation could improve treatment outcomes for children globally Isra Zaman4 Aug 2023 9:30 AM ISTResearchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation...
No nationwide shortage of HIV drug Dolutegravir: Mansukh Mandaviya MD Bureau3 Aug 2023 5:30 PM ISTNew Delhi: Union Health and Family Welfare Minister Mansukh Mandaviya on Tuesday told the Parliament that there is no nation-wide shortage of HIV drug...
Laurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS treatment Ruchika Sharma2 May 2023 4:24 PM ISTHyderabad: Laurus Labs Ltd., a R&D driven pharmaceutical & biotech manufacturing company in India, has announced the receipt of the US Food...
HIV drug may be linked to increased risk of hypertension Dr. Kamal Kant Kohli7 March 2023 8:00 PM ISTIn 2019, the World Health Organization formally recommended the drug dolutegravir (DTG) as the preferred antiretroviral therapy (ART) for people...
Lupin bags tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets to control HIV infections Ruchika Sharma31 Jan 2023 3:30 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...
